Remarkably, CCL2 and CXCL10, both of which are increased in patients developing a systemic inflammatory response syndrome following SARS-CoV-2 infections (44), showed a strong hypoxic induction upon subsequent infection with SARS-CoV-2 (Figure 5D). This evidence concerns the gene CXCL10 and systemic inflammatory response syndrome.